VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume $151.49 +1.56 (+1.04%) Closing price 03:57 PM EasternExtended Trading$151.92 +0.43 (+0.28%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Short Interest DataVanEck Biotech ETF (BBH) has a short interest of 11,200 shares, representing 0.49% of the float (the number of shares available for trading by the public). This marks a 761.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 8,347 shares to cover all short positions.Current Short Interest11,200 sharesPrevious Short Interest1,300 sharesChange Vs. Previous Month+761.54%Dollar Volume Sold Short$1.65 millionShort Interest Ratio1.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares2,290,000 sharesShort Percent of Float0.49%Today's Trading Volume5,459 sharesAverage Trading Volume8,347 sharesToday's Volume Vs. Average65% Short Selling VanEck Biotech ETF? Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBBH Short Interest Over TimeBBH Days to Cover Over TimeBBH Percentage of Float Shorted Over Time VanEck Biotech ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202511,200 shares $1.65 million +761.5%0.5%1 $147.74 3/31/20251,300 shares $204,542.00 -58.1%0.1%0.1 $157.34 3/15/20253,100 shares $504,246.00 -73.3%0.1%0.3 $162.66 2/28/202511,600 shares $1.91 million +427.3%0.5%1.1 $164.58 2/15/20252,200 shares $353,232.00 -24.1%0.1%0.2 $160.56 1/31/20252,900 shares $479,225.00 +107.1%N/A0.3 $165.25 1/15/20251,400 shares $223,258.00 -17.7%N/A0.1 $159.47 12/31/20241,700 shares $266,849.00 +112.5%N/A0.2 $156.97 12/15/2024800 shares $130,736.00 -96.4%N/A0.1 $163.42 11/30/202422,500 shares $3.77 million +2,712.5%N/A3.7 $167.37 Get the Latest News and Ratings for BBH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024800 shares $126,328.00 +33.3%N/A0.2 $157.91 10/31/2024600 shares $101,778.00 -45.5%N/A0.1 $169.63 10/15/20241,100 shares $196,070.38 +57.1%N/A0.2 $178.25 9/30/2024700 shares $124,173.00 +75.0%N/A0.1 $177.39 9/15/2024400 shares $72,480.00 -55.6%N/A0.1 $181.20 8/31/2024900 shares $163,017.00 -84.2%N/A0.1 $181.13 8/15/20245,700 shares $1.02 million +58.3%N/A0.9 $179.18 7/31/20243,600 shares $649,332.00 -5.3%N/A0.6 $180.37 7/15/20243,800 shares $669,674.00 -57.8%N/A0.6 $176.23 6/30/20249,000 shares $1.52 million -23.7%N/A1.3 $168.41 6/15/202411,800 shares $1.97 million +521.1%N/A1.5 $166.85 5/31/20241,900 shares $312,721.00 -34.5%N/A0.3 $164.59 5/15/20242,900 shares $489,085.00 +38.1%N/A0.4 $168.65 4/30/20242,100 shares $327,684.00 -16.0%N/A0.3 $156.04 4/15/20242,500 shares $387,800.00 -68.0%N/A0.3 $155.12 3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33 3/15/20242,500 shares $407,950.00 +25.0%N/A0.3 $163.18 2/29/20242,000 shares $325,480.00 +185.7%N/A0.2 $162.74 2/15/2024700 shares $114,422.00 -22.2%N/A0.1 $163.46 1/31/2024900 shares $148,950.00 -87.3%N/A0.1 $165.50 1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38 12/31/20233,600 shares $595,116.00 -62.5%N/A0.3 $165.31 12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42 11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70 11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53 10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38 10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83 9/30/20235,600 shares $872,088.00 No ChangeN/A0.9 $155.73 9/15/20235,600 shares $897,344.00 -9.7%N/A0.8 $160.24 8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 8/15/20233,400 shares $551,820.00 +70.0%N/A0.5 $162.30 7/31/20232,000 shares $321,560.00 -23.1%N/A0.3 $160.78 7/15/20232,600 shares $409,292.00 +8.3%N/A0.4 $157.42 6/30/20232,400 shares $374,520.00 -7.7%N/A0.4 $156.05 6/15/20232,600 shares $420,394.00 -13.3%N/A0.4 $161.69 5/31/20233,000 shares $463,890.00 No ChangeN/A0.4 $154.63 5/15/20233,000 shares $483,960.00 -52.4%N/A0.4 $161.32 4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73 4/15/20235,500 shares $913,165.00 +22.2%N/A0.5 $166.03 3/31/20234,500 shares $729,405.00 +95.7%N/A0.4 $162.09 3/15/20232,300 shares $360,479.00 +4.6%N/A0.2 $156.73 2/28/20232,200 shares $343,838.00 -74.1%N/A0.2 $156.29 2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77 1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74 1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27 12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74 12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75 11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16 11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95 10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23 10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46 9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78 9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60 8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98 8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51 7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31 7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63 6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79 6/15/20225,400 shares $734,292.00 +12.5%N/A0.2 $135.98 5/31/20224,800 shares $710,352.00 -61.9%N/A0.2 $147.99 5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14 4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38 4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50 3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13 3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67 2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06 2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10 1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90 1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62 12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34 12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44 11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79 11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45 10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50 10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82 9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14 9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28 8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12 8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07 7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 7/15/202113,500 shares $2.65 million -20.6%N/A0.9 $196.29 6/30/202117,000 shares $3.43 million -18.7%N/A1.2 $201.67 6/15/202120,900 shares $4.07 million -21.4%N/A1.5 $194.51 5/28/202126,600 shares $4.90 million +33.0%N/A2.3 $184.15 5/14/202120,000 shares $3.47 million +7.5%N/A1.8 $173.72 4/30/202118,600 shares $3.49 million +47.6%N/A1.5 $187.70 4/15/202112,600 shares $2.27 million -8.0%N/A1 $180.28 3/31/202113,700 shares $2.34 million +12.3%N/A1.1 $170.72 3/15/202112,200 shares $2.12 million -15.3%N/A0.9 $174.02 2/26/202114,400 shares $2.57 million -28.7%N/A1 $178.53 2/12/202120,200 shares $3.88 million +59.1%N/A1.2 $191.95 1/29/202112,700 shares $2.32 million -41.7%N/A0.7 $182.68 1/15/202121,800 shares $3.92 million +7.9%N/A1.3 $180.01 12/31/202020,200 shares $3.43 million -8.6%N/A1.2 $169.82 12/15/202022,100 shares $3.86 million -40.6%N/A1.3 $174.74 11/30/202037,200 shares $6.14 million -7.9%N/A2.1 $165.02 11/15/202040,400 shares $6.57 million +12.9%N/A2.2 $162.67 10/30/202035,800 shares $5.59 million -2.2%N/A1.9 $156.14 10/15/202036,600 shares $6.10 million -22.5%N/A0 $166.68 9/30/202047,200 shares $7.65 million -43.6%N/A2 $162.08 9/15/202045,100 shares $7.19 million -46.1%N/A1.6 $159.42 8/31/202083,700 shares $13.43 million -1.0%N/A2.8 $160.45 8/14/202084,500 shares $13.64 million -13.4%N/A2.7 $161.45 7/31/202097,600 shares $16.09 million +4.7%N/A2.9 $164.85 7/15/202093,200 shares $15.87 million -17.7%N/A2.8 $170.33 6/30/2020113,200 shares $18.17 million +141.9%N/A3.3 $160.47 6/15/202046,800 shares $7.31 million +3.5%N/A1.4 $156.15 5/29/202045,200 shares $7.09 million -37.8%N/A1.3 $156.84 5/15/202072,700 shares $11.24 million +48.1%N/A2.1 $154.67 BBH Short Interest - Frequently Asked Questions What is VanEck Biotech ETF's current short interest? Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,200 shares of BBH short. 0.49% of VanEck Biotech ETF's shares are currently sold short. Learn More on VanEck Biotech ETF's current short interest. What is a good short interest ratio for VanEck Biotech ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBH shares currently have a short interest ratio of 1.0. Learn More on VanEck Biotech ETF's short interest ratio. What is a good short interest percentage for VanEck Biotech ETF? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.49% of VanEck Biotech ETF's floating shares are currently sold short. Is VanEck Biotech ETF's short interest increasing or decreasing? VanEck Biotech ETF saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 11,200 shares, an increase of 761.5% from the previous total of 1,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Biotech ETF's short interest compare to its competitors? 0.49% of VanEck Biotech ETF's shares are currently sold short. Here is how the short interest of companies compare to VanEck Biotech ETF: Invesco Dorsey Wright Healthcare Momentum ETF (0.21%), ProShares Ultra Nasdaq Biotechnology (1.22%), VanEck Pharmaceutical ETF (41.19%), Invesco Nasdaq Biotechnology ETF (0.14%), First Trust Nasdaq Pharmaceuticals ETF (0.05%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (4.44%), and iShares Biotechnology ETF (23.58%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Biotech ETF stock? Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading up $1.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Biotech ETF? A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further. How often is VanEck Biotech ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Invesco Dorsey Wright Healthcare Momentum ETF Short Squeeze ProShares Ultra Nasdaq Biotechnology Short Squeeze VanEck Pharmaceutical ETF Short Squeeze Invesco Nasdaq Biotechnology ETF Short Squeeze First Trust Nasdaq Pharmaceuticals ETF Short Squeeze JPMorgan Healthcare Leaders ETF Short Squeeze ProShares UltraShort Nasdaq Biotechnology Short Squeeze iShares Biotechnology ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBH) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
